Fragment-based drug discovery: Less is more

被引:0
|
作者
Heightman, Tom D. [1 ]
机构
[1] Astex Pharmaceut Inc, Cambridge, England
关键词
PROTEINS; IAP;
D O I
10.1158/1538-7445.AM2014-SY05-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SY05-01
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Introduction to the themed collection on fragment-based drug discovery
    Rees, David C.
    Hirsch, Anna K. H.
    Erlanson, Daniel A.
    RSC MEDICINAL CHEMISTRY, 2022, 13 (12): : 1439 - 1439
  • [42] Computational methods to enable Fragment-Based Drug Discovery
    Murray, Chris W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [43] Fragment-based drug discovery: From crystal to clinic
    Patel, Joe
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C37 - C37
  • [44] Fragment-based drug discovery at adaptive protein sites
    Erlanson, Daniel A.
    FASEB JOURNAL, 2007, 21 (05): : A209 - A209
  • [45] Informatics and modeling challenges in fragment-based drug discovery
    Hubbard, Roderick E.
    Chen, Ijen
    Davis, Ben
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (03) : 289 - 297
  • [46] MEDICINAL CHEMISTRY INSPIRED FRAGMENT-BASED DRUG DISCOVERY
    Lanter, James
    Zhang, Xuqing
    Sui, Zhihua
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 421 - 445
  • [47] Fragment-based drug discovery: A medicinal chemists perspective
    Woodhead, Andrew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [48] Fragment-based Drug Discovery: the Shape of Things to Come
    Drysdale, Martin J.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (12) : 1544 - 1549
  • [49] Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV
    Mallakuntla, Mohan Krishna
    Togre, Namdev S.
    Santos, Destiny B.
    Tiwari, Sangeeta
    PHARMACEUTICALS, 2022, 15 (11)
  • [50] Extrapolating the Fragment-Based Approach to Inorganic Drug Discovery
    Batchelor, Lucinda K.
    Dyson, Paul J.
    TRENDS IN CHEMISTRY, 2019, 1 (07): : 644 - 655